BUSINESS

Pfizer deals extend patent life for a top-selling rare disease drug

Apr 29, 2026 - 23:00
Pfizer deals extend patent life for a top-selling rare disease drug
Read More

Tags:

Previous Article

Solaris Energy Infrastructure, Inc. Q1 2026 Earnings Call Summary

Next Article

Are Wall Street Analysts Bullish on Bank of America Stock?

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Analyst Report: Thomson-Reuters Corp

Analyst Report: Thomson-Reuters Corp

Apr 22, 2026

Grenergy inks 12-year tolling agreement for Escuderos storage

Grenergy inks 12-year tolling agreement for Escuderos s...

Apr 27, 2026

Amazon.com Inc. (AMZN) Gains Analyst Support on Strong AWS and AI Demand

Amazon.com Inc. (AMZN) Gains Analyst Support on Strong ...

Apr 23, 2026